Universitätspublikationen
Refine
Year of publication
- 2018 (1307) (remove)
Document Type
- Article (897)
- Doctoral Thesis (113)
- Working Paper (107)
- Preprint (75)
- Part of Periodical (40)
- Conference Proceeding (30)
- Part of a Book (21)
- Report (9)
- Review (9)
- Book (3)
Language
- English (1307) (remove)
Has Fulltext
- yes (1307)
Is part of the Bibliography
- no (1307)
Keywords
- Financial Institutions (9)
- breast cancer (9)
- inflammation (8)
- Neuroscience (7)
- Research article (7)
- Germany (6)
- Inflammation (6)
- Liquidity (6)
- Macro Finance (6)
- aging (6)
Institute
- Medizin (454)
- Physik (213)
- Wirtschaftswissenschaften (131)
- Frankfurt Institute for Advanced Studies (FIAS) (96)
- Sustainable Architecture for Finance in Europe (SAFE) (95)
- Center for Financial Studies (CFS) (94)
- Biowissenschaften (90)
- Informatik (69)
- House of Finance (HoF) (62)
- Biochemie und Chemie (58)
- Institut für Ökologie, Evolution und Diversität (52)
- Senckenbergische Naturforschende Gesellschaft (47)
- Gesellschaftswissenschaften (44)
- Psychologie (33)
- Biochemie, Chemie und Pharmazie (32)
- Biodiversität und Klima Forschungszentrum (BiK-F) (30)
- Pharmazie (29)
- Exzellenzcluster Makromolekulare Komplexe (26)
- Sonderforschungsbereiche / Forschungskollegs (26)
- Geowissenschaften (24)
- Neuere Philologien (21)
- Sportwissenschaften (20)
- Informatik und Mathematik (18)
- E-Finance Lab e.V. (17)
- Rechtswissenschaft (16)
- Zentrum für Biomolekulare Magnetische Resonanz (BMRZ) (16)
- Exzellenzcluster Die Herausbildung normativer Ordnungen (13)
- Sprach- und Kulturwissenschaften (13)
- MPI für Hirnforschung (12)
- Georg-Speyer-Haus (11)
- Kulturwissenschaften (10)
- Institute for Monetary and Financial Stability (IMFS) (9)
- MPI für Biophysik (8)
- Deutsches Institut für Internationale Pädagogische Forschung (DIPF) (7)
- Erziehungswissenschaften (7)
- Exzellenzcluster Herz-Lungen-System (7)
- Geographie (7)
- MPI für empirische Ästhetik (6)
- Präsidium (5)
- Starker Start ins Studium: Qualitätspakt Lehre (5)
- Buchmann Institut für Molekulare Lebenswissenschaften (BMLS) (4)
- ELEMENTS (4)
- LOEWE-Schwerpunkt für Integrative Pilzforschung (4)
- Philosophie (4)
- Zentrum für Interdisziplinäre Afrikaforschung (ZIAF) (4)
- Institut für Sozialforschung (IFS) (3)
- Psychologie und Sportwissenschaften (3)
- Center for Membrane Proteomics (CMP) (2)
- Center for Scientific Computing (CSC) (2)
- DFG-Forschergruppen (2)
- Evangelische Theologie (2)
- Extern (2)
- Geowissenschaften / Geographie (2)
- Goethe-Zentrum für Wissenschaftliches Rechnen (G-CSC) (2)
- Interdisziplinäres Zentrum für Neurowissenschaften Frankfurt (IZNF) (2)
- Mathematik (2)
- Sprachwissenschaften (2)
- Ernst Strüngmann Institut (1)
- Gleichstellungsbüro (1)
- Institut für sozial-ökologische Forschung (ISOE) (1)
- Institute for Law and Finance (ILF) (1)
- LOEWE-Schwerpunkt Außergerichtliche und gerichtliche Konfliktlösung (1)
- Universität des 3. Lebensalters e.V. (1)
- Universitätsbibliothek (1)
The mechanistic target of the rapamycin (mTOR) inhibitor, temsirolimus, has significantly improved the outcome of patients with renal cell carcinoma (RCC). However, development of temsirolimus-resistance limits its effect and metastatic progression subsequently recurs. Since integrin α7 (ITGA7) is speculated to promote metastasis, this investigation was designed to investigate whether temsirolimus-resistance is associated with altered ITGA7 expression in RCC cell lines and modified tumor cell adhesion and invasion. Caki-1, KTCTL-26, and A498 RCC cell lines were driven to temsirolimus-resistance by exposing them to temsirolimus over a period of 12 months. Subsequently, adhesion to human umbilical vein endothelial cells, to immobilized fibronectin, or collagen was investigated. Chemotaxis was evaluated with a modified Boyden chamber assay and ITGA7 expression by flow cytometry and western blotting. Chemotaxis significantly decreased in temsirolimus-sensitive cell lines upon exposure to low-dosed temsirolimus, but increased in temsirolimus-resistant tumor cells upon reexposure to the same temsirolimus dose. The increase in chemotaxis was accompanied by elevated ITGA7 at the cell surface membrane with simultaneous reduction of intracellular ITGA7. ITGA7 knock-down significantly diminished motility of temsirolimous-sensitive cells but elevated chemotactic activity of temsirolimus-resistant Caki-1 and KTCTL-26 cells. Therefore, ITGA7 appears closely linked to adhesion and migration regulation in RCC cells. It is postulated that temsirolimus-resistance is associated with translocation of ITGA7 from inside the cell to the outer surface. This switch forces RCC migration forward. Whether ITGA7 can serve as an important target in combatting RCC requires further investigation.
Natural Killer (NK) cells are involved in the host immune response against infections due to viral, bacterial and fungal pathogens, all of which are a significant cause of morbidity and mortality in immunocompromised patients. Since the recovery of the immune system has a major impact on the outcome of an infectious complication, there is major interest in strengthening the host response in immunocompromised patients, either by using cytokines or growth factors or by adoptive cellular therapies transfusing immune cells such as granulocytes or pathogen-specific T-cells. To date, relatively little is known about the potential of adoptively transferring NK cells in immunocompromised patients with infectious complications, although the anti-cancer property of NK cells is already being investigated in the clinical setting. This review will focus on the antimicrobial properties of NK cells and the current standing and future perspectives of generating and using NK cells as immunotherapy in patients with infectious complications, an approach which is promising and might have an important clinical impact in the future.
Early and adequate restoration of endothelial and tubular renal function is a substantial step during regeneration after ischemia reperfusion (IR) injury, occurring, e.g., in kidney transplantation, renal surgery, and sepsis. While tubular epithelial cell injury has long been of central importance, recent perception includes the renal vascular endothelium. In this regard, the fibrin cleavage product fibrinopeptide Bβ15-42 mitigate IR injury by stabilizing interendothelial junctions through its affinity to VE-cadherin. Therefore, this study focused on the effect of Bβ15-42 on post-acute physiological renal regeneration. For this, adult male C57BL/6 mice were exposed to a 30 min bilateral renal ischemia and reperfusion for 24 h or 48 h. Animals were randomized in a non-operative control group, two operative groups each treated with i.v. administration of either saline or Bβ15-42 (2.4 mg/kg) immediately prior to reperfusion. Endothelial activation and inflammatory response was attenuated in renal tissue homogenates by single application of Bβ15-42. Meanwhile, Bβ15-42 did not affect acute kidney injury markers. Regarding the angiogenetic players VEGF-A, Angiopoietin-1, Angiopoietin-2, however, we observed significant higher expressions at mRNA and trend to higher protein level in Bβ15-42 treated mice, compared to saline treated mice after 48 h of IR, thus pointing toward an increased angiogenetic activity. Similar dynamics were observed for the intermediate filament vimentin, the cytoprotective protein klotho, stathmin and the proliferation cellular nuclear antigen, which were significantly up-regulated at the same points in time. These results suggest a beneficial effect of anatomical contiguously located endothelial cells on tubular regeneration through stabilization of endothelial integrity. Therefore, it seems that Bβ15-42 represents a novel pharmacological approach in the targeted therapy of acute renal failure in everyday clinical practice.
The myocyte enhancer factor 2 (MEF2) regulates transcription in cardiac myocytes and adverse remodeling of adult hearts. Activators of G protein‐coupled receptors (GPCRs) have been reported to activate MEF2, but a comprehensive analysis of GPCR activators that regulate MEF2 has to our knowledge not been performed. Here, we tested several GPCR agonists regarding their ability to activate a MEF2 reporter in neonatal rat ventricular myocytes. The inflammatory mediator prostaglandin E2 (PGE2) strongly activated MEF2. Using pharmacological and protein‐based inhibitors, we demonstrated that PGE2 regulates MEF2 via the EP3 receptor, the βγ subunit of Gi/o protein and two concomitantly activated downstream pathways. The first consists of Tiam1, Rac1, and its effector p21‐activated kinase 2, the second of protein kinase D. Both pathways converge on and inactivate histone deacetylase 5 (HDAC5) and thereby de‐repress MEF2. In vivo, endotoxemia in MEF2‐reporter mice induced upregulation of PGE2 and MEF2 activation. Our findings provide an unexpected new link between inflammation and cardiac remodeling by de‐repression of MEF2 through HDAC5 inactivation, which has potential implications for new strategies to treat inflammatory cardiomyopathies.
Recent experiments have demonstrated that visual cortex engages in spatio-temporal sequence learning and prediction. The cellular basis of this learning remains unclear, however. Here we present a spiking neural network model that explains a recent study on sequence learning in the primary visual cortex of rats. The model posits that the sequence learning and prediction abilities of cortical circuits result from the interaction of spike-timing dependent plasticity (STDP) and homeostatic plasticity mechanisms. It also reproduces changes in stimulus-evoked multi-unit activity during learning. Furthermore, it makes precise predictions regarding how training shapes network connectivity to establish its prediction ability. Finally, it predicts that the adapted connectivity gives rise to systematic changes in spontaneous network activity. Taken together, our model establishes a new conceptual bridge between the structure and function of cortical circuits in the context of sequence learning and prediction.
The enzyme acetyl-CoA carboxylase (ACC) plays a fundamental role in the fatty acid metabolism. It regulates the first and rate limiting step in the biosynthesis of fatty acids by catalyzing the carboxylation of acetyl-CoA to malonyl-CoA and exists as two different isoforms, ACC1 and ACC2. In the last few years, ACC has been reported as an attractive drug target for treating different diseases, such as insulin resistance, hepatic steatosis, dyslipidemia, obesity, metabolic syndrome and nonalcoholic fatty liver disease. An altered fatty acid metabolism is also associated with cancer cell proliferation. In general, the inhibition of ACC provides two possibilities to regulate the fatty acid metabolism: It blocks the de novo lipogenesis in lipogenic tissues and stimulates the mitochondrial fatty acid β-oxidation. Surprisingly, the role of ACC in human vascular endothelial cells has been neglected so far. This work aimed to investigate the role of the ACC/fatty acid metabolism in regulating important endothelial cell functions like proliferation, migration and tube formation.
To investigate the function of ACC, the ACC-inhibitor soraphen A as well as an siRNA-based approach were used. This study revealed that ACC1 is the predominant isoform both in human umbilical vein endothelial cells (HUVECs) and in human dermal microvascular endothelial cells (HMECs). Inhibition of ACC via soraphen A resulted in decreased levels of malonyl-CoA and shifted the lipid composition of endothelial cell membranes. Consequently, membrane fluidity, filopodia formation and the migratory capacity were attenuated. Increasing amounts of longer acyl chains within the phospholipid subgroup phosphatidylcholine (PC) were suggested to overcompensate the shift towards shorter acyl chains within phosphatidylglycerol (PG), which resulted in a dominating effect on regulating the membrane fluidity. Most importantly, this work provided a link between changes in the phospholipid composition and altered endothelial cell migration. The antimigratory effect of soraphen A was linked to a reduced amount of PG and to an increased amount of polyunsaturated fatty acids (PUFAs) within the phospholipid cell membrane. This link was unknown in the literature so far. Interestingly, a reduced filopodia formation was observed upon ACC inhibition via soraphen A, which presumably caused the impaired migratory capacity.
This work revealed a relationship between ACC/fatty acid metabolism, membrane lipid composition and endothelial cell migration. The natural compound soraphen A emerged as a valuable chemical tool to analyze the role of ACC/fatty acid metabolism in regulating important endothelial cell functions. Furthermore, regulating endothelial cell migration via ACC inhibition promises beneficial therapeutic perspectives for the treatment of cell migration-related disorders, such as ischemia reperfusion injury, diabetic angiopathy, macular degeneration, rheumatoid arthritis, wound healing defects and cancer.
Quantum chromodynamics (QCD) is the theory of the strong interaction between quarks and gluons. Due to Confinement, at lower energies quarks and gluons are bound into colorless states called hadrons. QCD is also asymptotically free, i.e. at large energies or densities it enters a deconfined state, termed quark-gluon plasma (QGP), where quarks and gluons are quasi-free. This transition occurs at an energy scale around 200 MeV where QCD cannot be treated perturbatively. Instead it can be formulated on a space-time grid. The resulting theory, lattice quantum chromodynamics (LQCD), can be simulated efficiently on high performance parallel-computing clusters. In recent years graphic processing units (GPUs), which outperform CPUs in terms of parallel-computing and memory bandwidth capabilities, became very popular for LQCD computations. In this work the QCD deconfinement transition is studied using CL2QCD, a LQCD application that runs efficiently on GPUs. Furthermore, CL2QCD is extended by a Rational Hybrid Monte Carlo algorithm for Wilson fermions to allow for simulations of an odd number of quark flavors.
Due to the sign-problem LQCD simulations are restricted to zero or very small baryon densities, where, in the limit of infinite quark mass QCD has a first order deconfinement phase transition associated to the breaking of the global centre symmetry. Including dynamical quarks breaks this symmetry explicitly. Lowering their mass weakens the first order transition until it terminates in a second order Z2 point. Beyond this point the transition is merely an analytic crossover. As the lattice spacing is decreased, the reduction of discretization errors causes the region of first order transitions to expand towards lower masses. In this work the deconfinement critical point with 2 and 3 flavors of standard Wilson fermions is studied. To this end several kappa values are simulated on temporal lattice extents 6,8,10 (4) for two flavors (three flavors) and various aspect ratios (spatial lattice extent / temporal lattice extent) so as to extrapolate to the thermodynamic limit, applying finite size scaling. For two flavors an estimate is done if and when a continuum extrapolation is possible.
The chiral and deconfinement phase transitions at zero density for light and heavy quarks, respectively, have analytic continuations to purely imaginary chemical potential, where no sign-problem exists and LQCD simulations can be applied. At some critical value of the imaginary chemical potential, the transitions meet the endpoint of the Roberge-Weiss transition between adjacent Z3 sectors. For light and heavy quarks the transition lines meet in a triple point, while for intermediate masses they meet in a second order point. At the boundary between these regimes the junction is a tricritical point, as shown in studies with two and three flavors of staggered and Wilson quarks on lattices with a temporal lattice extent of 4. Employing finite size scaling the nature of this point as a function of the quark mass is studied in this work for two flavors of Wilson fermions with a temporal lattice extent of 6. Of particular interest is the change of the location of tricritical points compared to an earlier study on lattices with temporal extent of 4.
Based on an original dataset of 100 important pieces of legislation passed during the three presidencies of William J. Clinton, George W. Bush, and Barack H. Obama (1992-2013), this study explores two sets of questions:
(1) How do presidents influence legislators in Congress in the legislative arena, and what factors have an effect on the legislative strategies presidents choose?
(2) How successful are presidents in getting their policy positions enacted into law, and what configurations of institutional and actor-centered conditions determine presidential legislative success?
The analyses show that in an hyper-polarized environment, presidents usually have to fight an uphill-battle in the legislative arena, getting more involved if they face less favorable contexts and the odds are against them.
Moreover, the analyses suggest that there is no silver-bullet approach for presidents' legislative success. Instead, multiple patterns of success exist as presidents - depending on the institutional and public environment - can resort to different combinations of actions in order to see their preferred policy outcomes enacted.
Primary cilia are microtubule-based organelles that detect mechanical and chemical stimuli. Although cilia house a number of oncogenic molecules (including Smoothened, KRAS, EGFR, and PDGFR), their precise role in cancer remains unclear. We have interrogated the role of cilia in acquired and de novo resistance to a variety of kinase inhibitors, and found that, in several examples, resistant cells are distinctly characterized by an increase in the number and/or length of cilia with altered structural features. Changes in ciliation seem to be linked to differences in the molecular composition of cilia and result in enhanced Hedgehog pathway activation. Notably, manipulating cilia length via Kif7 knockdown is sufficient to confer drug resistance in drug-sensitive cells. Conversely, targeting of cilia length or integrity through genetic and pharmacological approaches overcomes kinase inhibitor resistance. Our work establishes a role for ciliogenesis and cilia length in promoting cancer drug resistance and has significant translational implications.